Respiratory Rehabilitation of COVID-19 Patients: Current State of the Problem
https://doi.org/10.31550/1727-2378-2023-22-2-70-75
Abstract
Objective of the Review: To summarise the data from literature sources on respiratory rehabilitation of patients with the novel coronavirus infection; to assess the current state and perspectives.
Key Points. The novel coronavirus infection (COVID-19) is a highly contagious acute respiratory disease with primary involvement of upper and lower respiratory tract, organs and systems of the body. The symptoms of the disease vary from asymptomatic carrier to clinically severe viral pneumonia that requires oxygen therapy and respiratory support. Respiratory rehabilitation is vital for patient recovery. Globally, there is more and more professional information and databases on respiratory rehabilitation of COVID-19 patients, since the common methods of rehabilitation after a respiratory disease can be ineffective or unsafe.
Conclusion. Respiratory rehabilitation should be an integral part of COVID-19 therapy, starting from ICU once the patient’s condition has stabilised. Rehabilitation should be personalised. Future studies will help in understanding the development path of pulmonary rehabilitation in order to improve the quality of patients’ life and to facilitate faster activity restoration.
About the Authors
K. V. Petrov
Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak St., Krasnoyarsk, 660022
E. Yu. Mozheyko
Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak St., Krasnoyarsk, 660022
A. V. Petrov
Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak St., Krasnoyarsk, 660022
I. V. Demko
Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak St., Krasnoyarsk, 660022
References
1. Brugliera L., Spina A., Castellazzi P. et al. Rehabilitation of COVID-19 patients. J. Rehabil. Med. 2020;52(4):jrm00046. DOI: 10.2340/16501977-2678
2. Bubnova M.G., Shlyakhto E.V., Aronov D.M. et al. Coronavirus disease 2019: features of comprehensive cardiac and pulmonary rehabilitation. Russian Journal of Cardiology. 2021;26(5):4487. (in Russian). DOI: 10.15829/1560-4071-2021-4487
3. Kabysh S.S., Karpenkova A.D., Prokopenko S.V. Cognitive impairments and COVID-19. Siberian Medical Review. 2022;(2):40–48. (in Russian). DOI: 10.20333/25000136-2022-2-40-48
4. Ma-Van-de V.D., Zaitsev D.N., Filev A.P. et al. Clinical and laboratory markers of severity of the new coronavirus infection (COVID-19). Siberian Medical Review. 2022;(3):40–48. (in Russian). DOI: 10.20333/25000136-2022-3-40-48
5. Forchette L., Sebastian W., Liu T. A Comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics. Curr. Med. Sci. 2021;41(6):1037–1051. DOI: 10.1007/s11596-021-2395-1
6. Davies N.G., Abbott S., Barnard R.C. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055. DOI: 10.1126/science.abg3055
7. Leung K., Shum M.H., Leung G.M. et al. Early transmissibility assessment of the n501y mutant strains of sars-cov-2 in the United Kingdom, October to November 2020. EuroSurveill.2021;26:2002106. DOI: 10.2807/1560-7917.ES.2020.26.1.2002106
8. Volz E., Mishra S., Chand M. et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature. 2021;593(7858):266–269. DOI: 10.1038/s41586-021-03470-x
9. Public-Health-England. Investigation of novel SARS-CoV-2 variants of concern. (2021). URL: https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201
10. Pearson C.A.B., Russell T.W., Davies N., Kucharski A.J. Estimates of severity and transmissibility of novel South Africa SARS-CoV-2 Variant 501Y.V2 (2021). URL: https://cmmidgithubio/topics/covid19/sa-novel-variant.html
11. Volz E., Hill V., McCrone J.T., Price A. et. al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184(1):64–75.e11. DOI: 10.1016/j.cell.2020.11.020
12. Wang P., Casner R.G., Nair M.S. et al. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. bioRxiv [Preprint]. 2021: 2021.03.01.433466. DOI: 10.1101/2021.03.01.433466
13. Campbell F., Archer B., Laurenson-Schafer H. et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill. 2021;26(24):2100509. DOI: 10.2807/1560-7917.ES.2021.26.24.2100509
14. SARS-CoV-2 Variants of concern and variants under investigation in England (2021). URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001358/Variants_of_Concern_VOC_Technical_Briefing_18.pdf
15. Sheikh A., McMenamin J., Taylor B., Robertson C. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397(10293):2461–2462. DOI: 10.1016/S0140-6736(21)01358-1
16. Khedar R.S., Mittal K., Ambaliya H.C. et al. Greater COVID-19 severity and mortality in hospitalized patients in second (Delta Variant) wave compared to the first: single centre prospective study in India. medRxiv. 2021; 2021.09.03.21263091. DOI: 10.1101/2021.09.03.21263091
17. Sheikhzadegan S., Alaghemand N., Fox M., Venkataraman V. Analysis of the delta variant B.1.617.2 COVID-19. Clin. Pract. 2021;11(4):778–784. DOI: 10.3390/clinpract11040093
18. Araf Y., Akter F., Tang Y.D. et al. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. J. Med. Virol. 2022;94(5):1825–1832. DOI: 10.1002/jmv.27588/
19. Vaporidi K., Akoumianaki E., Telias I. et al. Respiratory drive in critically ill patients. Pathophysiology and clinical implications. Am. J. Respir. Crit. Care Med. 2020;201(1):20–32. DOI: 10.1164/rccm.201903-0596SO
20. Manning H.L., Schwartzstein R.M. Pathophysiology of dyspnea. N. Engl. J. Med. 1995;333(23):1547–1553. DOI: 10.1056/NEJM199512073332307
21. Torres-Torrelo H., Ortega-Sáenz P., Gao L., López-Barneo J. Lactate sensing mechanisms in arterial chemoreceptor cells. Nat. Commun. 2021;12(1):4166. DOI: 10.1038/s41467-021-24444-7
22. Dhont S., Derom E., Van Braeckel E. et al. The pathophysiology of 'happy' hypoxemia in COVID-19. Respir. Res. 2020;21(1):198. DOI: 10.1186/s12931-020-01462-5
23. Lippi G., Henry B.M. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir. Med. 2020;167:105941. DOI: 10.1016/j.rmed.2020.105941
24. Pericàs J.M., Hernandez-Meneses M., Sheahan T.P. et al. COVID-19: from epidemiology to treatment. Eur. Heart J. 2020;41(22):2092–2112. DOI: 10.1093/eurheartj/ehaa462
25. Wu C., Chen X., Cai Y. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180(7):934–943. DOI: 10.1001/jamainternmed.2020.0994
26. Parohan M., Yaghoubi S., Seraji A. et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416–1424. DOI: 10.1080/13685538.2020.1774748
27. Interim guidelines “Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19). Version 6 (28.04.2020)». 18 p. (in Russian). URL: https://static1.rosminzdrav.ru/system/attachments/attaches/000/050/122/original/28042020_%D0%9CR_COVID-19_v6.pdf
28. Siddiq M.A.B., Rathore F.A., Clegg D., Rasker J.J. Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pandemic. Turk. J. Phys. Med. Rehabil. 2020;66(4):480–494. DOI: 10.5606/tftrd.2020.6889
29. Spruit M.A., Singh S.J., Garvey C. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013; 188(8): e13–e64. DOI: 10.1164/rccm.201309-1634ST
30. Yang X., Yu Y., Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8(5):475–481. DOI: 10.1016/S2213-2600(20)30079-5
31. Levy J., Léotard A., Lawrence C. et.al. A model for a ventilator-weaning and early rehabilitation unit to deal with post-ICU impairments following severe COVID-19. Ann. Phys. Rehabil. Med. 2020;63(4):376–378. DOI: 10.1016/j.rehab.2020.04.002
32. Simpson R., Robinson L. Rehabilitation following critical illness in people with COVID-19 infection. Am. J. Phys. Med. Rehabil. 2020; 10.1097/PHM.0000000000001443. DOI: 10.1097/PHM.0000000000001443
33. Thomas P., Baldwin C., Bissett B., Boden I. et. al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J. Physiother. 2020;66(2):73–82. DOI: 10.1016/j.jphys.2020.03.011
34. Wang T.J., Chau B., Lui M. et al. Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am. J. Phys. Med. Rehabil. 2020;99(9):769–774. DOI: 10.1097/PHM.0000000000001505
35. Yang F., Liu N., Hu J.Y. et al. Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV). Zhonghua Jie He He Hu Xi Za Zhi. 2020.12;43(3):180–182. DOI: 10.3760/cma.j.issn.1001-0939.2020.03.007
36. Fink J.B. Positioning versus postural drainage. Respir. Care. 2002;47(7):769–777.
37. Cullen D.L., Rodak B. Clinical utility of measures of breathlessness. Respir. Care. 2002;47(9):986–993.
38. Gautam A.P., Arena R., Dixit S., Borghi-Silva A. Pulmonary rehabilitation in COVID-19 pandemic era: The need for a revised approach. Respirology. 2020;25(12):1320–1322. DOI: 10.1111/resp.13946
39. Parry S.M., Knight L.D., Connolly B. et. al. Factors influencing physical activity and rehabilitation in survivors of critical illness: a systematic review of quantitative and qualitative studies. Intensive Care Med. 2017;43(4):531–542. DOI: 10.1007/s00134-017-4685-4
40. Temporary guidelines «Medical rehabilitation for a new coronavirus infection (COVID-19). Version 2 (31.07.2020)». 151 p. (in Russian). URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/187/original/31072020_Reab_COVID-19_v1.pdf
41. Zhao H.M., Xie Y.X., Wang C et al. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin. Med. J. (Engl.). 2020;133(13):1595–1602. DOI: 10.1097/CM9.0000000000000848
42. Grigoletto I., Cavalheri V., Lima F.F., Ramos E.M.C. Recovery after COVID-19: The potential role of pulmonary rehabilitation. Braz. J. Phys. Ther. 2020;24(6):463–464. DOI: 10.1016/j.bjpt.2020.07.002
43. Barazzoni R., Bischoff S.C., Breda J. et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin. Nutr. 2020;39(6):1631–1638. DOI: 10.1016/j.clnu.2020.03.022
44. Carfì A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. DOI: 10.1001/jama.2020.12603
45. Khan F., Amatya B. Medical rehabilitation in pandemics: towards a new perspective. J. Rehabil. Med. 2020;52(4):jrm00043. DOI: 10.2340/16501977-2676
46. Ambrosino N., Fracchia C. The role of tele-medicine in patients with respiratory diseases. Expert Rev. Respir. Med. 2017;11(11):893–900. DOI: 10.1080/17476348.2017.1383898
47. Yang L.L., Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Dis. Transl. Med. 2020;6(2):79–86. DOI: 10.1016/j.cdtm.2020.05.002
48. Liu K., Zhang W., Yang Y. et al. Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Complement Ther. Clin. Pract. 2020;39:101166. DOI: 10.1016/j.ctcp.2020.101166
49. Donner C.F., Raskin J., ZuWallack R. et al. Incorporating telemedicine into the integrated care of the COPD patient a summary of an interdisciplinary workshop held in Stresa, Italy, 7-8 September 2017. Respir. Med. 2018;143:91–102. DOI: 10.1016/j.rmed.2018.09.003
50. Bartlo P., Bauer N. Pulmonary rehabilitation post-acute care for COVID-19 (PACER). URL: https://youtu.be/XjY_7O3Qpd8 (data of access: 11.05.2020).
Review
For citations:
Petrov K.V., Mozheyko E.Yu., Petrov A.V., Demko I.V. Respiratory Rehabilitation of COVID-19 Patients: Current State of the Problem. Title. 2023;22(2):70-75. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-2-70-75
Views:
24
Email this article 